Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)

Recruiting Observational Study
Peripheral Vascular Diseases Cardiovascular Disease Type 2 Diabetes Peripheral Artery Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Canadian Medical and Surgical Knowledge Translation Research Group · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
PAD-VRCE is an observational, cross-sectional, two arm study aimed at determining if the presence of peripheral artery disease (PAD) can influence the number of circulating regenerative cells in blood. From peripheral blood samples, circulating progenitor cell content will be assessed via flow cytometry and compared between individuals with PAD and individuals without PAD. Ultimately, this study p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adults ≥18 and ≤80 years of age who meet either of the following criteria: 1. Clinically significant/symptomatic PAD (defined as symptomatic claudication with and an ankle brachial index of less than 0.85). 2. No history of PAD. 2. Willing and able to provide written i…
Contacts

Jack Casey

604-703-5449

jackcasey21@rcsi.ie

CONTACT

Aishwarya Krishnaraj, BScH

aishy.krishnaraj@mail.utoronto.ca

CONTACT